Editorial & Opinion
أعرض في EDS

Celiprolol and sympatho-immune interface in COVID-19.

التفاصيل البيبلوغرافية
العنوان: Celiprolol and sympatho-immune interface in COVID-19.
المؤلفون: Al-Kuraishy HM; Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq., Albuhadily AK; Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq., Al-Gareeb AI; Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq., El-Bouseary MM; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Tanta University, Tanta, Egypt., Alexiou A; Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, New South Wales, Australia.; AFNP Med, Wien, Austria., Papadakis M; Department of Surgery II, University Hospital Witten-Herdecke, University of Witten-Herdecke, Wuppertal, Germany., Batiha GE; Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, AlBeheira, Egypt.
المصدر: Immunology [Immunology] 2023 Dec; Vol. 170 (4), pp. 579-582. Date of Electronic Publication: 2023 Sep 07.
نوع المنشور: Letter
اللغة: English
بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0374672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2567 (Electronic) Linking ISSN: 00192805 NLM ISO Abbreviation: Immunology Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Oxford : Blackwell Scientific Publications
مواضيع طبية MeSH: Celiprolol* , COVID-19*, Humans
References: Al-Kuraishy HM, Al-Gareeb AI, Almulaiky YQ, Cruz-Martins N, El-Saber Batiha GE. Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: the enigmatic entity. Eur J Pharmacol. 2021;904:174196. https://doi.org/10.1016/j.ejphar.2021.174196.
Al-Kuraishy HM, Al-Gareeb AI, Mostafa-Hedeab G, Kasozi KI, Zirintunda G, Aslam A, et al. Effects of β-blockers on the sympathetic and cytokines storms in Covid-19. Front Immunol. 2021;12:749291. https://doi.org/10.3389/fimmu.2021.749291.
Lamyel F, Warnken-Uhlich M, Seemann WK, Mohr K, Kostenis E, Ahmedat AS, et al. The β2-subtype of adrenoceptors mediates inhibition of pro-fibrotic events in human lung fibroblasts. Naunyn Schmiedebergs Arch Pharmacol. 2011;384(2):133-145. https://doi.org/10.1007/s00210-011-0655-5.
Wu L, Tai Y, Hu S, Zhang M, Wang R, Zhou W, et al. Bidirectional role of β2-adrenergic receptor in autoimmune diseases. Front Pharmacol. 2018;9:1313. https://doi.org/10.3389/fphar.2018.01313.
Nossent AY, Dai L, Rosendaal FR, Vos HL, Eikenboom JC. Beta 2 adrenergic receptor polymorphisms: association with factor VIII and Von Willebrand factor levels and the risk of venous thrombosis. J Thromb Haemost. 2005;3(2):405-407. https://doi.org/10.1111/j.1538-7836.2005.01109.x.
Alomair BM, Al-Kuraishy HM, Al-Gareeb AI, Al-Buhadily AK, Alexiou A, Papadakis M, et al. Mixed storm in SARS-CoV-2 infection: a narrative review and new term in the Covid-19 era. Immun Inflamm Dis. 2023;11(4):e838.
Abdelkrim MA, Martignat L, Gogny M, Desfontis JC, Noireaud J, Mallem MY. Celiprolol induces β3-adrenoceptors-dependent relaxation in isolated porcine coronary arteries. Can J Physiol Pharmacol. 2013;91(10):791-796. https://doi.org/10.1139/cjpp-2013-0091.
Baderkhan H, Wanhainen A, Stenborg A, Stattin EL, Björck M. Celiprolol treatment in patients with vascular Ehlers-Danlos syndrome. Eur J Vasc Endovasc Surg. 2021;61(2):326-331. https://doi.org/10.1016/j.ejvs.2020.10.020.
Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000;52(4):595-638.
Nawarskas JJ, Cheng-Lai A, Frishman WH. Celiprolol: a unique selective adrenoceptor modulator. Cardiol Rev. 2017;25(5):247-253. https://doi.org/10.1097/CRD.0000000000000159.
Andrzejczak D, Górska D. The effects of celiprolol on serum concentrations of proinflammatory cytokines in hypertensive (SHR) and normotensive (WKY) rats. Pharmacol Rep. 2014;66(1):68-73. https://doi.org/10.1016/j.pharep.2013.08.006.
Araujo LP, Maricato JT, Guereschi MG, Takenaka MC, Nascimento VM, de Melo FM, et al. The sympathetic nervous system mitigates CNS autoimmunity via β2-adrenergic receptor signaling in immune cells. Cell Rep. 2019;28(12):3120-3130.e5. https://doi.org/10.1016/j.celrep.2019.08.042.
Scanzano A, Cosentino M. Adrenergic regulation of innate immunity: a review. Front Pharmacol. 2015;6:171. https://doi.org/10.3389/fphar.2015.00171.
Kurbatov BK, Prokudina ES, Maslov LN, Naryzhnaya NV, Logvinov SV, Gorbunov AS, et al. The role of adrenergic and muscarinic receptors in stress-induced cardiac injury. Pflugers Arch. 2021;473(10):1641-1655. https://doi.org/10.1007/s00424-021-02602-6.
Onohuean H, Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Batiha GE. Covid-19 and development of heart failure: mystery and truth. Naunyn Schmiedebergs Arch Pharmacol. 2021;394:2013-2021.
Al-Kuraishy HM, Al-Gareeb AI, Welson NN, Batiha GE. Trimetazidine and COVID-19-induced acute cardiac injury: a missed key. Int J Clin Pharm. 2022;44(3):832-833.
Kizaki T, Izawa T, Sakurai T, Haga S, Taniguchi N, Tajiri H, et al. β2-Adrenergic receptor regulates toll-like receptor-4-induced nuclear factor-κB activation through β-arrestin 2. Immunology. 2008;124(3):348-356. https://doi.org/10.1111/j.1365-2567.2007.02781.x.
Batiha GE, Al-Gareeb AI, Elekhnawy E, Al-Kuraishy HM. Potential role of lipoxin in the management of COVID-19: a narrative review. Inflammopharmacology. 2022;30(6):1993-2001.
Al-Kuraishy HM, Al-Gareeb AI, Saad HM, Batiha GE. The effect of ramatroban on cytokine and thrombotic storms in Covid-19. Inflammopharmacology. 2023;31(1):543-545.
Calvani M, Bruno G, Dal Monte M, Nassini R, Fontani F, Casini A, et al. β3-Adrenoceptor as a potential immuno-suppressor agent in melanoma. Br J Pharmacol. 2019;176(14):2509-2524. https://doi.org/10.1111/bph.14660.
Henriquez AR, Snow SJ, Schladweiler MC, Miller CN, Dye JA, Ledbetter AD, et al. Adrenergic and glucocorticoid receptor antagonists reduce ozone-induced lung injury and inflammation. Toxicol Appl Pharmacol. 2018;339:161-171. https://doi.org/10.1016/j.taap.2017.12.006.
McCarthy C, Kokosi M, Bonella F. Shaping the future of an ultra-rare disease: unmet needs in the diagnosis and treatment of pulmonary alveolar proteinosis. Curr Opin Pulm Med. 2019;25(5):450-458. https://doi.org/10.1097/MCP.0000000000000601.
Vasanthakumar N. Beta-adrenergic blockers as a potential treatment for COVID-19 patients. BioEssays. 2020;42(11):2000094.
Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, et al. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. 2020;382(25):2441-2448.
Barbieri A, Robinson N, Palma G, Maurea N, Desiderio V, Botti G. Can beta-2-adrenergic pathway be a new target to combat SARS-CoV-2 hyperinflammatory syndrome?-lessons learned from cancer. Front Immunol. 2020;11:588724.
Clemente-Moragón A, Martínez-Milla J, Oliver E, Santos A, Flandes J, Fernández I, et al. Metoprolol in critically ill patients with COVID-19. J Am Coll Cardiol. 2021;78(10):1001-1011.
المشرفين على المادة: DRB57K47QC (Celiprolol)
تواريخ الأحداث: Date Created: 20230907 Date Completed: 20231106 Latest Revision: 20231108
رمز التحديث: 20240628
DOI: 10.1111/imm.13693
PMID: 37679864
قاعدة البيانات: MEDLINE
الوصف
تدمد:1365-2567
DOI:10.1111/imm.13693